Your browser doesn't support javascript.
loading
A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors.
Papadopoulos, Kyriakos P; Kelley, Robin Kate; Tolcher, Anthony W; Razak, Albiruni R Abdul; Van Loon, Katherine; Patnaik, Amita; Bedard, Philippe L; Alfaro, Ariceli A; Beeram, Muralidhar; Adriaens, Lieve; Brownstein, Carrie M; Lowy, Israel; Kostic, Ana; Trail, Pamela A; Gao, Bo; DiCioccio, A Thomas; Siu, Lillian L.
Afiliação
  • Papadopoulos KP; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas. Kyri.Papadopoulos@start.stoh.com.
  • Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Tolcher AW; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas.
  • Razak AR; Princess Margaret Cancer Centre, Toronto, Ontario.
  • Van Loon K; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Patnaik A; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas.
  • Bedard PL; Princess Margaret Cancer Centre, Toronto, Ontario.
  • Alfaro AA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
  • Beeram M; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas.
  • Adriaens L; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Brownstein CM; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Kostic A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Trail PA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Gao B; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • DiCioccio AT; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
  • Siu LL; Princess Margaret Cancer Centre, Toronto, Ontario.
Clin Cancer Res ; 22(6): 1348-55, 2016 Mar 15.
Article em En | MEDLINE | ID: mdl-26490310
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiopoietina-2 / Anticorpos Monoclonais Humanizados / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiopoietina-2 / Anticorpos Monoclonais Humanizados / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article